Actinium Pharmaceuticals to Participate in the Oppenheimer & Co. Boston Oncology Insights Summit on August 16-17, 2017 Aug 9, 2017
Actinium Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common Stock Aug 2, 2017
Actinium Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock Jul 28, 2017
Actinium Announces Proposed Public Offering of Common Stock and Warrants to Purchase Stock Jul 27, 2017
Actinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ET Jul 13, 2017
Actinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ET Jul 6, 2017
Actinium Pharmaceuticals Issues Mid-Year Letter to Shareholders Highlighting Accomplishments and Significant Value Enumerating Catalysts Over the Coming Quarters Jun 15, 2017
Actinium Pharmaceuticals Announces Appointment of Nitya Ray, Ph.D. as Executive Vice-President, Head of Product Development, Manufacturing and Supply Chain and Other Key Hires in its Product Development and Manufacturing Teams Jun 15, 2017
Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B Jun 12, 2017
